1. Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J. Clin. Pathol. 2001; 54; 762–765. 2. Non-operative diagnosis subgroup of the National Coordinating Committee for Breast Screening Pathology. Guidelines for nonoperative diagnostic procedures and reporting in breast cancer screening. NHSBSP Publication Number 50. Sheffield: NHS Breast Screening Programme Publications 2001. 3. Schwartz IS, Strauchen JA. Lymphocytic mastopathy. An autoimmmune disease of the breast? Am. J. Clin. Pathol. 1990; 93; 725–730. 4. Soler NG, Khardori R. Fibrous disease of the breast, thyroiditis and cheiroarthropathy in Type 1 diabetes mellitus. Lancet 1984; 1; 193–195. 5. Lammie GA, Bobrow LG, Staunton MDM, Levison DA, Page G, Millis RR. Sclerosing lymphocytic lobulitis of the breast— evidence for an autoimmune pathogenesis. Histopathology 1991; 19; 13–20. 6. Pluchinotta AM, Talenti E, Lodovichetti G et al. Diabetic fibrous breast disease: a clinical entity that mimics cancer. Eur. J. Surg. Oncol. 1995; 21; 207–209. 7. Andrews-Tang D, Diamond AB, Rogers L et al. Diabetic mastopathy adjunctive use of ultrasound and utility of core biopsy in diagnosis. Breast J. 2000; 6; 183–188. 8. Taniere P, Poulard G, Frappart L et al. Diabetic mastopathy with epithelioid fibroblasts: differential diagnosis from an infiltrating lobular carcinoma of the breast. Report of two cases. Annales Pathologie 1996; 16; 33–36. 9. Hunfield KP, Bässler R. Lymphocytic mastitis and fibrosis of the breast in long-standing insulin dependent diabetics. A histopathologic study on diabetic mastopathy and report of ten cases. Gen. Diagn. Pathol. 1997; 143; 49–58. 10. Tomaszewski JE, Brooks JSJ, Hicks D et al. Diabetic mastopathy: a distinct clinicopathologic entity.Hum. Pathol.1992; 23;780–786. 11. Black MM, Speer FD. Periductal lymphoid infiltrations in mammary tissue. Arch. Pathol. 1955; 60; 457–461. 12. Naidoo P, Chetty R. Lymphoepithelioma like carcinoma of the breast with associated sclerosing lymphocytic lobulitis. Arch. Pathol. Lab. Med. 2001; 125; 669–672. 13. Chetty R, Butler AE. Lymphocytic mastopathy associated with infiltrating lobular carcinoma. J. Clin. Pathol. 1993; 46; 376–377. 14. Lee AH, Happerfield LC, Millis RR et al. Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. Br. J. Cancer 1996; 74; 796–801. 15. Coyne JD, Baildam AD, Ashbury D. Lymphocytic mastopathy associated with ductal carcinoma in situ of the breast. Histopathology 1995; 26; 579–580.
[1]
S. Johnson,et al.
Galectin‐3 does not reliably distinguish benign from malignant thyroid neoplasms
,
2004,
Histopathology.
[2]
M. Papotti,et al.
Methodological considerations regarding the use of galectin-3 expression analysis in preoperative evaluation of thyroid nodules.
,
2003,
The Journal of clinical endocrinology and metabolism.
[3]
Z. Baloch,et al.
Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions.
,
2002,
Archives of pathology & laboratory medicine.
[4]
N. Dallimore,et al.
Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results?
,
2001,
Journal of clinical pathology.
[5]
R. Chetty,et al.
Lymphoepithelioma-like carcinoma of the breast with associated sclerosing lymphocytic lobulitis.
,
2001,
Archives of pathology & laboratory medicine.
[6]
L. Rogers,et al.
Diabetic Mastopathy: Adjunctive Use of Ultrasound and Utility of Core Biopsy in Diagnosis
,
2000,
The breast journal.
[7]
M. Papotti,et al.
Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry
,
1997,
Histopathology.
[8]
K. Hunfeld,et al.
Lymphocytic mastitis and fibrosis of the breast in long-standing insulin-dependent diabetics. A histopathologic study on diabetic mastopathy and report of ten cases.
,
1997,
General & diagnostic pathology.
[9]
L. Happerfield,et al.
Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
,
1996,
British Journal of Cancer.
[10]
A. Pluchinotta,et al.
Diabetic fibrous breast disease: a clinical entity that mimics cancer.
,
1995,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[11]
M. Black,et al.
Periductal lymphoid infiltrations in mammary tissue.
,
1955,
A.M.A. archives of pathology.